H_CD40(TNFRSF5) Reporter 293 Cell Line
Cat. No.
GM-C03829
Size
1 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
CD40 is a key cell surface receptor in the TNF receptor superfamily, primarily found on B cells, dendritic cells, macrophages, and some endothelial cells. Its main role is to regulate immune responses by promoting B cell proliferation, differentiation, and antibody production. When it binds to its ligand CD40L (expressed by activated T cells), CD40 activates various signaling pathways that enhance immune function.

CD40 signaling occurs through multiple pathways activated upon CD40L binding, including NF-Κb, MAPK (ERK, JNK, p38 MAPK), and PI3K/Akt. This activation triggers biological responses such as cell proliferation, survival, cytokine secretion, and immune memory formation, making CD40 crucial for regulating immune responses and maintaining immune tolerance.

H_CD40(TNFRSF5) Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the CD40 gene, along with signal-dependent expression of a luciferase reporter gene. When CD40L binds to CD40, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to CD40.
CD40 is a key cell surface receptor in the TNF receptor superfamily, primarily found on B cells, dendritic cells, macrophages, and some endothelial cells. Its main role is to regulate immune responses by promoting B cell proliferation, differentiation, and antibody production. When it binds to its ligand CD40L (expressed by activated T cells), CD40 activates various signaling pathways that enhance immune function.

CD40 signaling occurs through multiple pathways activated upon CD40L binding, including NF-Κb, MAPK (ERK, JNK, p38 MAPK), and PI3K/Akt. This activation triggers biological responses such as cell proliferation, survival, cytokine secretion, and immune memory formation, making CD40 crucial for regulating immune responses and maintaining immune tolerance.

H_CD40(TNFRSF5) Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the CD40 gene, along with signal-dependent expression of a luciferase reporter gene. When CD40L binds to CD40, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to CD40.
Data Display
Signaling Pathway
Response to Human CD40L Protein; His Tag. The H_CD40(TNFRSF5) Reporter 293 Cell Line (Cat. GM-C03829) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human CD40L Protein (Cat. GM-84919RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [44.2]. Data are shown by drug mass concentration.
Expression
H_CD40(TNFRSF5) Reporter 293 Cell Line(Cat. GM-C03829) was determined by flow cytometry using Anti-CD40 hIgG1 Reference Antibody (Tenebio) (Cat. GM-87983MAB).
Specifications
Cat. No GM-C03829
Product H_CD40(TNFRSF5) Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C03829
Product H_CD40(TNFRSF5) Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
EMEM ATCC/30-2003
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Human CD40L Protein; His Tag Genomeditech/GM-84919RP
Anti-CD40 hIgG1 Reference Antibody (Tenebio) Genomeditech/GM-87983MAB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
EMEM ATCC/30-2003
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Human CD40L Protein; His Tag Genomeditech/GM-84919RP
Anti-CD40 hIgG1 Reference Antibody (Tenebio) Genomeditech/GM-87983MAB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial revival, a higher number of dead cells and poor adherence are observed, which is normal. Adherence typically recovers within 2 - 3 days. After 2 - 3 passages, the proportion of adherent cells increases, and the cells begin to spread normally.

b)         After each passage, there may be 5 - 10% dead cells; however, as the number of passages increases, the recovery rate accelerates, the proportion of dead cells decreases, and the cell growth rate stabilizes.

c)          It is recommended to retain cell images after revival and during each observation to assist in assessing cell status. In case of abnormalities, promptly communicate with Genomeditech sales.

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial revival, a higher number of dead cells and poor adherence are observed, which is normal. Adherence typically recovers within 2 - 3 days. After 2 - 3 passages, the proportion of adherent cells increases, and the cells begin to spread normally.

b)         After each passage, there may be 5 - 10% dead cells; however, as the number of passages increases, the recovery rate accelerates, the proportion of dead cells decreases, and the cell growth rate stabilizes.

c)          It is recommended to retain cell images after revival and during each observation to assist in assessing cell status. In case of abnormalities, promptly communicate with Genomeditech sales.

Related products
CD40:CD40L
H_CD40(TNFRSF5) Reporter Jurkat Cell Line Cynomolgus_CD40 CHO-K1 Cell Line Cynomolgus_CD40L CHO-K1 Cell Line
H_CD40(TNFRSF5) CHO-K1 Cell Line H_CD40(TNFRSF5) HEK-293 Cell Line H_CD40L CHO-K1 Cell Line
H_CD40L HEK-293 Cell Line Mouse_CD40L CHO-K1 Cell Line Rabbit_CD40L NIH-3T3 Cell Line
Anti-CD40 hIgG1 Reference Antibody (Sotibio) Anti-CD40 hIgG1 Reference Antibody (Tenebio) Anti-CD40L hIgG1 Reference Antibody (Frebio)
Anti-H_CD40 hIgG1 Antibody(APX005M) Anti-H_CD40 hIgG1 Antibody(ravagalimab) Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
Anti-H_CD40L hIgG1 Antibody(frexalimab)
Biotinylated Human CD40 Protein; His-Avi Tag Cynomolgus CD40 Protein; His Tag Human CD40 Protein; His Tag
Human CD40L Protein; His Tag    
IFN-α
IFNα Reporter HEK-293 Cell Line IFNα Reporter MDCK Cell Line IFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell Line H_BAFFR Reporter Cell Line H_BCMA Reporter Cell Line
H_TACI Reporter Cell Line Cynomolgus_BCMA CHO-K1 Cell Line Cynomolgus_BCMA HEK-293 Cell Line
H_BCMA CHO-K1 Cell Line H_BCMA HEK-293 Cell Line
Anti-BAFF hIgG1 Antibody(belimumab) Anti-BAFF hIgG4 Reference Antibody (Tababio) Anti-BAFFR hIgG1 Antibody(ianalumab)
Anti-BCMA hIgG1 Antibody(Belantamab) Anti-BCMA hIgG1 Antibody(SEA-BCMA) Anti-BCMA hIgG4 Antibody(BCMB69)
Anti-CD3E×BCMA hIgG4 Reference Antibody (Tecbio) Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio)
Biotinylated Human BAFF Protein; His-Avi Tag Biotinylated Human BCMA Protein; His-Avi Tag Cynomolgus BAFF Protein; His Tag
Cynomolgus BCMA Protein; hFc Tag Cynomolgus BCMA Protein; His Tag Human APRIL Protein; hFc Tag
Human BAFF Protein; His Tag Human BCMA Protein; hFc Tag Human BCMA Protein; His Tag
Mouse BAFF Protein; His Tag    
BDCA2(CLEC4C)
H_BDCA2 Reporter DDX35TM Jurkat Cell Line H_BDCA2 Reporter Jurkat Cell Line Cynomolgus_BDCA2 CHO-K1 Cell Line
Cynomolgus_BDCA2 Jurkat Cell Line H_BDCA2 CHO-K1 Cell Line H_BDCA2 HEK-293 Cell Line
H_BDCA2 Jurkat Cell Line
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)
Cynomolgus BDCA2 Protein; His Tag Human BDCA2 Protein; His Tag  
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_CD40(TNFRSF5) Reporter 293 Cell Line
Cat. No.
GM-C03829
Size
1 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
CD40 is a key cell surface receptor in the TNF receptor superfamily, primarily found on B cells, dendritic cells, macrophages, and some endothelial cells. Its main role is to regulate immune responses by promoting B cell proliferation, differentiation, and antibody production. When it binds to its ligand CD40L (expressed by activated T cells), CD40 activates various signaling pathways that enhance immune function.

CD40 signaling occurs through multiple pathways activated upon CD40L binding, including NF-Κb, MAPK (ERK, JNK, p38 MAPK), and PI3K/Akt. This activation triggers biological responses such as cell proliferation, survival, cytokine secretion, and immune memory formation, making CD40 crucial for regulating immune responses and maintaining immune tolerance.

H_CD40(TNFRSF5) Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the CD40 gene, along with signal-dependent expression of a luciferase reporter gene. When CD40L binds to CD40, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to CD40.

CD40 is a key cell surface receptor in the TNF receptor superfamily, primarily found on B cells, dendritic cells, macrophages, and some endothelial cells. Its main role is to regulate immune responses by promoting B cell proliferation, differentiation, and antibody production. When it binds to its ligand CD40L (expressed by activated T cells), CD40 activates various signaling pathways that enhance immune function.

CD40 signaling occurs through multiple pathways activated upon CD40L binding, including NF-Κb, MAPK (ERK, JNK, p38 MAPK), and PI3K/Akt. This activation triggers biological responses such as cell proliferation, survival, cytokine secretion, and immune memory formation, making CD40 crucial for regulating immune responses and maintaining immune tolerance.

H_CD40(TNFRSF5) Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the CD40 gene, along with signal-dependent expression of a luciferase reporter gene. When CD40L binds to CD40, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to CD40.

Data Display
Signaling Pathway
Response to Human CD40L Protein; His Tag. The H_CD40(TNFRSF5) Reporter 293 Cell Line (Cat. GM-C03829) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human CD40L Protein (Cat. GM-84919RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [44.2]. Data are shown by drug mass concentration.
Expression
H_CD40(TNFRSF5) Reporter 293 Cell Line(Cat. GM-C03829) was determined by flow cytometry using Anti-CD40 hIgG1 Reference Antibody (Tenebio) (Cat. GM-87983MAB).
Specifications
Cat. No GM-C03829
Product H_CD40(TNFRSF5) Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C03829
Product H_CD40(TNFRSF5) Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
EMEM ATCC/30-2003
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Human CD40L Protein; His Tag Genomeditech/GM-84919RP
Anti-CD40 hIgG1 Reference Antibody (Tenebio) Genomeditech/GM-87983MAB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
EMEM ATCC/30-2003
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Human CD40L Protein; His Tag Genomeditech/GM-84919RP
Anti-CD40 hIgG1 Reference Antibody (Tenebio) Genomeditech/GM-87983MAB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial revival, a higher number of dead cells and poor adherence are observed, which is normal. Adherence typically recovers within 2 - 3 days. After 2 - 3 passages, the proportion of adherent cells increases, and the cells begin to spread normally.

b)         After each passage, there may be 5 - 10% dead cells; however, as the number of passages increases, the recovery rate accelerates, the proportion of dead cells decreases, and the cell growth rate stabilizes.

c)          It is recommended to retain cell images after revival and during each observation to assist in assessing cell status. In case of abnormalities, promptly communicate with Genomeditech sales.

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: EMEM+10% FBS+1% P.S+3 μg/mL Blasticidin+1.5 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial revival, a higher number of dead cells and poor adherence are observed, which is normal. Adherence typically recovers within 2 - 3 days. After 2 - 3 passages, the proportion of adherent cells increases, and the cells begin to spread normally.

b)         After each passage, there may be 5 - 10% dead cells; however, as the number of passages increases, the recovery rate accelerates, the proportion of dead cells decreases, and the cell growth rate stabilizes.

c)          It is recommended to retain cell images after revival and during each observation to assist in assessing cell status. In case of abnormalities, promptly communicate with Genomeditech sales.

Related products
CD40:CD40L
H_CD40(TNFRSF5) Reporter Jurkat Cell Line Cynomolgus_CD40 CHO-K1 Cell Line Cynomolgus_CD40L CHO-K1 Cell Line
H_CD40(TNFRSF5) CHO-K1 Cell Line H_CD40(TNFRSF5) HEK-293 Cell Line H_CD40L CHO-K1 Cell Line
H_CD40L HEK-293 Cell Line Mouse_CD40L CHO-K1 Cell Line Rabbit_CD40L NIH-3T3 Cell Line
Anti-CD40 hIgG1 Reference Antibody (Sotibio) Anti-CD40 hIgG1 Reference Antibody (Tenebio) Anti-CD40L hIgG1 Reference Antibody (Frebio)
Anti-H_CD40 hIgG1 Antibody(APX005M) Anti-H_CD40 hIgG1 Antibody(ravagalimab) Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
Anti-H_CD40L hIgG1 Antibody(frexalimab)
Biotinylated Human CD40 Protein; His-Avi Tag Cynomolgus CD40 Protein; His Tag Human CD40 Protein; His Tag
Human CD40L Protein; His Tag    
IFN-α
IFNα Reporter HEK-293 Cell Line IFNα Reporter MDCK Cell Line IFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell Line H_BAFFR Reporter Cell Line H_BCMA Reporter Cell Line
H_TACI Reporter Cell Line Cynomolgus_BCMA CHO-K1 Cell Line Cynomolgus_BCMA HEK-293 Cell Line
H_BCMA CHO-K1 Cell Line H_BCMA HEK-293 Cell Line
Anti-BAFF hIgG1 Antibody(belimumab) Anti-BAFF hIgG4 Reference Antibody (Tababio) Anti-BAFFR hIgG1 Antibody(ianalumab)
Anti-BCMA hIgG1 Antibody(Belantamab) Anti-BCMA hIgG1 Antibody(SEA-BCMA) Anti-BCMA hIgG4 Antibody(BCMB69)
Anti-CD3E×BCMA hIgG4 Reference Antibody (Tecbio) Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio)
Biotinylated Human BAFF Protein; His-Avi Tag Biotinylated Human BCMA Protein; His-Avi Tag Cynomolgus BAFF Protein; His Tag
Cynomolgus BCMA Protein; hFc Tag Cynomolgus BCMA Protein; His Tag Human APRIL Protein; hFc Tag
Human BAFF Protein; His Tag Human BCMA Protein; hFc Tag Human BCMA Protein; His Tag
Mouse BAFF Protein; His Tag    
BDCA2(CLEC4C)
H_BDCA2 Reporter DDX35TM Jurkat Cell Line H_BDCA2 Reporter Jurkat Cell Line Cynomolgus_BDCA2 CHO-K1 Cell Line
Cynomolgus_BDCA2 Jurkat Cell Line H_BDCA2 CHO-K1 Cell Line H_BDCA2 HEK-293 Cell Line
H_BDCA2 Jurkat Cell Line
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)
Cynomolgus BDCA2 Protein; His Tag Human BDCA2 Protein; His Tag  
Message consultation
reset
submit
Message
Message consultation
reset
submit